Compounds > atractylenolide iii
Page last updated: 2024-09-04

atractylenolide iii and Liver Cirrhosis

atractylenolide iii has been researched along with Liver Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gu, Y; Liu, H; Qi, L; Wu, H; Wu, L; Xiao, L; Zhang, L; Zhang, M1
Chen, N; Ke, C; Liu, Y; Shi, K; Tu, J; Wang, B; Wang, Y; Zhou, Z1

Other Studies

2 other study(ies) available for atractylenolide iii and Liver Cirrhosis

ArticleYear
Atractylenolide III suppresses senescence-associated secretome via inhibiting cGAS/NF-κB pathway in hepatic stellate cells.
    Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:4

    Topics: Cellular Senescence; Etoposide; Hepatic Stellate Cells; Humans; Liver Cirrhosis; NF-kappa B; Nucleotidyltransferases; Secretome

2023
Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism.
    Molecules (Basel, Switzerland), 2023, Jul-19, Volume: 28, Issue:14

    Topics: Animals; Bile Ducts; Fibrosis; Glutamine; Liver; Liver Cirrhosis; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt

2023